Malware and threat analysis provider VMRay secures €3.5 million Series A investment

VMRAY-team-logo

VMRay, a German tech company and provider of 3rd generation agentless threat analysis and detection, today announced it has closed €3.5 million in Series A funding with eCAPITAL entrepreneurial Partners AG and High-Tech Gründerfonds (HTGF). VMRay will use the fresh capital to accelerate its product development roadmap and expand its sales and marketing worldwide.

Since VMRay’s entry to market at the beginning of 2015, many of the world’s largest global enterprises and leading technology vendors have come to rely on VMRay for automated evasion-resistant threat analysis and detection that works on-premises or in the cloud. With this round of funding, VMRay will establish a U.S. office in Boston for North American customer support and worldwide sales and marketing. The Bochum (Germany) based company will also expand the research and development team, led by co-founder and CTO Ralf Hund, in its Bochum, Germany head office in order to continue to broaden its offering and maintain its competitive lead.

“This is further validation of the unique malware analysis technology that VMRay has developed. Our approach can give enterprises the edge in battling relentless and ever-more sophisticated cyberattacks. The skills and specific expertise to tackle these threats are in short supply among organizations worldwide,” said VMRay CEO and co-founder Carsten Willems. He continued: “An automated analysis tool such as VMRay that easily integrates into existing security infrastructure enables enterprises to effectively leverage the resources they already have, while dramatically improving their visibility into the threat landscape, whereby improving their ability to react and defend.”

VMRay’s agentless automated threat analysis solution leverages hypervisor-centric technology and a unique monitoring approach developed through years of research by the co-founders. By embedding monitoring and control of the target analysis environment in the hypervisor, VMRay Analyzer avoids the malware evasion and scalability challenges that hamper other approaches.

Willi Mannheims, Managing Partner of eCAPITAL stated: “The product is ready for commercialization, thus we view this financing as an acceleration round. We are looking forward to helping facilitate the company’s growth as VMRay expands its offerings and market presence. VMRay already constitutes the fifth major investment by the eCAPITAL IV Technologies Fund, which was started in 2016.”

Holger Heinen, Investment Director of HTGF stated: “As the seed investor in VMRay, we saw early on the potential of their solution and the ability of the co-founders to execute their vision. When the opportunity arose to make a further investment, we didn’t hesitate. Given what the team has accomplished already, we know they will take VMRay into a leadership position in enterprise cybersecurity.”